The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Drug Abuse Testing Market Research Report 2025

Global Drug Abuse Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1714401

No of Pages : 75

Synopsis

Drugs of abuse testing is the detection of one or more illegal and/or prescribed substances in the urine, blood, saliva, hair, or sweat. Testing detects substances not normally found in the body, with the exception of some hormones and steroids measured as part of sports testing.

The global Drug Abuse Testing market was valued at US$ 18170 million in 2023 and is anticipated to reach US$ 28250 million by 2030, witnessing a CAGR of 6.6% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Drug Abuse Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Abuse Testing.

Report Scope

The Drug Abuse Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Abuse Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Abuse Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

  • Biomedical Diagnostics
  • BioMerieux
  • Abbott
  • Bio-Rad
  • Dako
  • DiaSorin
  • Eiken
  • Fujirebio
  • Beckman Coulter

Segment by Type

  • Random Testing
  • Reasonable Testing
  • Post accident Testing
  • Follow-up Testing

Segment by Application

  • Schools and Educational Institutes
  • Hospitals and Healthcare Units
  • Government and Private Departments

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Abuse Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Abuse Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Random Testing
1.2.3 Reasonable Testing
1.2.4 Post accident Testing
1.2.5 Follow-up Testing
1.3 Market by Application
1.3.1 Global Drug Abuse Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Schools and Educational Institutes
1.3.3 Hospitals and Healthcare Units
1.3.4 Government and Private Departments
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Abuse Testing Market Perspective (2019-2030)
2.2 Drug Abuse Testing Growth Trends by Region
2.2.1 Global Drug Abuse Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Abuse Testing Historic Market Size by Region (2019-2024)
2.2.3 Drug Abuse Testing Forecasted Market Size by Region (2025-2030)
2.3 Drug Abuse Testing Market Dynamics
2.3.1 Drug Abuse Testing Industry Trends
2.3.2 Drug Abuse Testing Market Drivers
2.3.3 Drug Abuse Testing Market Challenges
2.3.4 Drug Abuse Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Abuse Testing Players by Revenue
3.1.1 Global Top Drug Abuse Testing Players by Revenue (2019-2024)
3.1.2 Global Drug Abuse Testing Revenue Market Share by Players (2019-2024)
3.2 Global Drug Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Abuse Testing Revenue
3.4 Global Drug Abuse Testing Market Concentration Ratio
3.4.1 Global Drug Abuse Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Abuse Testing Revenue in 2023
3.5 Drug Abuse Testing Key Players Head office and Area Served
3.6 Key Players Drug Abuse Testing Product Solution and Service
3.7 Date of Enter into Drug Abuse Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Abuse Testing Breakdown Data by Type
4.1 Global Drug Abuse Testing Historic Market Size by Type (2019-2024)
4.2 Global Drug Abuse Testing Forecasted Market Size by Type (2025-2030)
5 Drug Abuse Testing Breakdown Data by Application
5.1 Global Drug Abuse Testing Historic Market Size by Application (2019-2024)
5.2 Global Drug Abuse Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Abuse Testing Market Size (2019-2030)
6.2 North America Drug Abuse Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Abuse Testing Market Size by Country (2019-2024)
6.4 North America Drug Abuse Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Abuse Testing Market Size (2019-2030)
7.2 Europe Drug Abuse Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Abuse Testing Market Size by Country (2019-2024)
7.4 Europe Drug Abuse Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Abuse Testing Market Size (2019-2030)
8.2 Asia-Pacific Drug Abuse Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Abuse Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Abuse Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Abuse Testing Market Size (2019-2030)
9.2 Latin America Drug Abuse Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Abuse Testing Market Size by Country (2019-2024)
9.4 Latin America Drug Abuse Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Abuse Testing Market Size (2019-2030)
10.2 Middle East & Africa Drug Abuse Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Abuse Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Abuse Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biomedical Diagnostics
11.1.1 Biomedical Diagnostics Company Detail
11.1.2 Biomedical Diagnostics Business Overview
11.1.3 Biomedical Diagnostics Drug Abuse Testing Introduction
11.1.4 Biomedical Diagnostics Revenue in Drug Abuse Testing Business (2019-2024)
11.1.5 Biomedical Diagnostics Recent Development
11.2 BioMerieux
11.2.1 BioMerieux Company Detail
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux Drug Abuse Testing Introduction
11.2.4 BioMerieux Revenue in Drug Abuse Testing Business (2019-2024)
11.2.5 BioMerieux Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Drug Abuse Testing Introduction
11.3.4 Abbott Revenue in Drug Abuse Testing Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Detail
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Drug Abuse Testing Introduction
11.4.4 Bio-Rad Revenue in Drug Abuse Testing Business (2019-2024)
11.4.5 Bio-Rad Recent Development
11.5 Dako
11.5.1 Dako Company Detail
11.5.2 Dako Business Overview
11.5.3 Dako Drug Abuse Testing Introduction
11.5.4 Dako Revenue in Drug Abuse Testing Business (2019-2024)
11.5.5 Dako Recent Development
11.6 DiaSorin
11.6.1 DiaSorin Company Detail
11.6.2 DiaSorin Business Overview
11.6.3 DiaSorin Drug Abuse Testing Introduction
11.6.4 DiaSorin Revenue in Drug Abuse Testing Business (2019-2024)
11.6.5 DiaSorin Recent Development
11.7 Eiken
11.7.1 Eiken Company Detail
11.7.2 Eiken Business Overview
11.7.3 Eiken Drug Abuse Testing Introduction
11.7.4 Eiken Revenue in Drug Abuse Testing Business (2019-2024)
11.7.5 Eiken Recent Development
11.8 Fujirebio
11.8.1 Fujirebio Company Detail
11.8.2 Fujirebio Business Overview
11.8.3 Fujirebio Drug Abuse Testing Introduction
11.8.4 Fujirebio Revenue in Drug Abuse Testing Business (2019-2024)
11.8.5 Fujirebio Recent Development
11.9 Beckman Coulter
11.9.1 Beckman Coulter Company Detail
11.9.2 Beckman Coulter Business Overview
11.9.3 Beckman Coulter Drug Abuse Testing Introduction
11.9.4 Beckman Coulter Revenue in Drug Abuse Testing Business (2019-2024)
11.9.5 Beckman Coulter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’